Single port surgery isn’t better for liver cancer, but it’s an option in selected cases. It uses one small incision instead of several, which looks neater and can mean less wound discomfort. The catch is it’s technically harder, suits only small tumours in favourable spots, and carries a higher hernia risk. For most liver cancers, standard keyhole or robotic resection remains the proven choice. It’s an option, not an upgrade.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “I’ll be straight about this, single port surgery isn’t a better operation for liver cancer, it’s a different access. For a small tumour in the right spot, it works well and leaves a neater scar. But it’s harder to do safely, and the evidence doesn’t show better cancer outcomes. I never trade oncological safety for one fewer incision. The tumour decides the approach, not the cosmetics.”

It’s a refinement of keyhole surgery, narrowing the access down to one point.

• One incision : Instead of several small cuts for separate instruments, everything goes through a single small incision, usually at the navel.
• The appeal : The main draw is cosmetic, a single hidden scar, along with potentially less wound pain than multiple port sites.
• Same operation inside : Once inside, the actual liver resection follows the same principles. The difference is purely in how the surgeon gets there.
• Small tumours only : It works for small, accessible tumours, often in the left lateral part of the liver. Bigger or deeper lesions don’t suit it.

This sits at the far end of laparoscopic cancer surgery, pushing the minimally invasive idea to its limit, but only where it’s genuinely safe.

The benefits are real but narrow, and the limits matter just as much.

• Not proven superior : There’s no solid evidence that single port surgery gives better cancer outcomes than standard keyhole resection. It’s feasible, not superior.
• Technically harder : Working through one port is more demanding. The instruments crowd each other, which is why it needs a very experienced surgeon.
• Higher hernia risk : That single larger incision carries a greater chance of an incisional hernia later than several tiny ones do.
• Narrow use : Only a small slice of liver cancers fit the criteria. For most, multi port or robotic surgery is simply the better, safer call.

What matters most isn’t the number of incisions but whether the cancer is removed properly, which our guide on liver cancer explains when it comes to cure.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. He offers the full range of minimally invasive liver surgery and chooses the approach on merit, not novelty, using single port only where it genuinely suits a small, favourable tumour. The approach puts cancer clearance first and cosmetics second, since a neat scar means nothing if the tumour isn’t removed completely.

The honest framing matters here. Single port surgery is a useful tool in a narrow set of cases, not a better operation for liver cancer in general. A surgeon who understands that won’t push it where standard keyhole or robotic resection is the safer, more complete choice. Matching the method to the tumour, and never trading cancer control for appearance, is the judgement that protects the patient.

References

1. Single port laparoscopic hepatectomy safety and feasibility — National Library of Medicine
2. Single incision laparoscopic approach in liver surgery — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Non-smokers can and do get lung cancer. Around one in ten cases occurs in people who never smoked, enough that if it were counted on its own, it would rank among the more common cancers. The causes are different: radon, air pollution, secondhand smoke, workplace exposures and genetics. It also behaves differently, often striking women and younger people, and frequently carrying mutations that respond well to targeted treatment.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “I’ve had patients look at me in disbelief because they never touched a cigarette in their lives. But roughly one in ten lung cancers is in a non-smoker, and it’s a genuinely different disease. It tends to be adenocarcinoma, often in women, and it frequently carries a mutation we can target directly. That last part is actually good news, because those cancers often respond beautifully to the right drug.”

When lung cancer appears in someone who never smoked, several factors are usually behind it.

• Radon and pollution : Radon gas seeping into homes, and long term air pollution, are major contributors. Both expose the lungs to carcinogens over years.
• Secondhand smoke : Breathing others’ smoke carries real risk. Years of passive exposure at home or work adds up, even without ever smoking yourself.
• Workplace exposures : Asbestos, diesel fumes and certain industrial chemicals raise lung cancer risk independently of smoking, sometimes decades after exposure.
• Genetics : A family history and inherited susceptibility play a bigger role in non-smokers, especially where cancer appeared young in relatives.

Recognising these different causes shapes the lung cancer treatment approach, since a non-smoker’s cancer often needs a different plan from a smoker’s.

Lung cancer in non-smokers isn’t just the same disease without the smoking. It’s genuinely distinct.

• Different type : It’s usually adenocarcinoma, which grows in the outer parts of the lung, rather than the central tumours more typical of smokers.
• Targetable mutations : Non-smoker cancers often carry mutations like EGFR or ALK. Drugs built for these can control the cancer remarkably well.
• Affects women more : For reasons still being studied, non-smoker lung cancer is diagnosed more often in women than in men.
• Better response : Partly because of those mutations, these cancers often respond better to treatment, and the outlook can be more favourable.

The contrast is clearest against the classic pattern, and understanding smoking and lung cancer shows just how different the two really are.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. He treats lung cancer in smokers and non-smokers alike, and pays close attention to the non-smoking group where molecular testing and targeted therapy change everything. The approach starts with not dismissing a lung mass just because someone never smoked, since that assumption is exactly what delays these diagnoses.

The important shift with non-smoker lung cancer is recognising it as its own disease. A non-smoker with a lung mass deserves the same thorough workup and molecular testing as anyone else, because the mutation found is often the key to treatment. Reading that correctly, and matching the therapy to the tumour’s biology, is what gives these patients some of the best outcomes in lung cancer care.

References

1. Risk factors for lung cancer among never smokers — National Library of Medicine
2. Lung cancer in never-smokers risk factors and driver mutations — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Robotic surgery is available for bile duct cancer, but only in selected cases at specialist centres. It suits resectable tumours that are clear of the major blood vessels, in patients fit for the operation. For these, the robot’s precision helps with the complex reconstruction this surgery demands. Complex or locally advanced tumours near major vessels still need open surgery. The case decides it.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “Robotic bile duct surgery is real and we do it, but I want to be honest about where it fits. For a resectable tumour that’s clear of the major vessels, the robot is excellent, especially for the delicate reconstruction afterward. But this is some of the most demanding surgery there is. A tumour wrapped around the portal vein still belongs in open hands. Right patient, right tool.”

The robotic approach works for bile duct cancer in a defined set of situations.

• Resectable tumour : The cancer has to be removable with clear margins. Robotic surgery doesn’t change what’s operable, it changes how it’s removed.
• Clear of vessels : Tumours sitting away from the portal vein and hepatic artery are far better suited. Proximity to those is what tips toward open.
• Complex reconstruction : After removal, the bile ducts need rejoining to the bowel. The robot’s wristed instruments handle this delicate step well.
• Specialist centre : This is high level hepatobiliary surgery. It needs a surgeon and team who do it regularly, not an occasional attempt.

This sits within the broader scope of robotic cancer surgery, where the platform’s precision matters most in technically demanding operations like this one.

Robotic surgery brings real advantages here, but it isn’t right for every bile duct cancer.

• Less blood loss : The precision and magnified view typically mean less bleeding, which matters greatly in this vessel rich part of the body.
• Faster recovery : Smaller incisions bring less pain and a quicker return home, the familiar benefits of a minimally invasive approach.
• Same cancer control : In suitable cases, the clear margin rates and oncological outcomes match open surgery. The goal of cure isn’t compromised.
• Where it stops : Tumours invading major vessels, or needing extended liver resection, remain open operations. The robot has genuine limits here.

The wider picture of bile duct surgery within hepatobiliary cancer care shows why these are among the most complex operations in the field.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. He was among the first in India to perform robotic procedures like the Whipple, and he brings that same robotic expertise to selected bile duct cancer cases. The approach starts with honest assessment of resectability, since the value of the robot is real only when the tumour genuinely suits it. That judgement protects the patient.

Bile duct cancer surgery is unforgiving, and the robotic version more so. The reconstruction alone demands a level of skill few surgeons have, which is why this work belongs in experienced hands and high volume centres. For the right patient with a resectable tumour, robotic surgery offers a real cure with a gentler recovery. Knowing which patient that is, and which one needs open surgery, is the expertise that matters most.

References

1. Robotic surgery for biliary tract cancer systematic review — National Library of Medicine
2. Minimally invasive surgery for perihilar cholangiocarcinoma — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

The difficult truth is lung cancer often has no early signs, which is exactly why it’s caught late. When signs do appear, the ones to watch are a cough that lingers or changes, breathlessness, chest pain worse on breathing, coughing up blood, and hoarseness. Recurrent chest infections and unexplained weight loss can feature too. These are easy to dismiss, and that’s the danger. Persistence is the signal to get checked.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “The hard part with lung cancer is that early on, it often whispers rather than shouts. A cough that won’t quit gets blamed on the weather or a lingering cold. But a cough lasting more than three weeks, or one that changes, deserves a look, especially in a smoker. None of these signs are dramatic. That’s exactly why people ignore them, and why we catch this cancer later than we should.”

These are the warning signs worth taking seriously, especially if they persist.

• A lasting cough : A cough that hangs on beyond three weeks, or an old smoker’s cough that suddenly changes, is the most common early clue.
• Coughing blood : Even a small amount of blood or rust coloured phlegm is a red flag. This one always needs prompt checking.
• Breathlessness : Getting unusually short of breath during everyday activities, without another clear cause, can be an early sign worth investigating.
• Chest pain : Pain that worsens with breathing, coughing or laughing, and doesn’t settle, is another signal not to brush aside.

Catching these early is what makes effective lung cancer treatment possible, since the stage at diagnosis shapes almost everything that follows.

The reasons lung cancer slips past early detection come down to how ordinary its signs seem.

• Non specific : A cough, tiredness, breathlessness. These overlap with dozens of harmless conditions, so cancer is rarely the first thought.
• Silent early : Small tumours often cause nothing at all. By the time symptoms appear, the cancer may already be more advanced.
• Blamed on smoking : Smokers often write off a cough as normal for them, missing the change that actually matters. The habit masks the warning.
• Slow creep : The signs build gradually rather than suddenly, so people adjust and adapt instead of getting checked. Weeks slip by.

Because smoking both causes the cancer and hides its signs, understanding smoking and lung cancer is central to knowing your own risk.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. He treats lung cancer with VATS and robotic thoracic surgery, and he sees early recognition as the part that changes outcomes most. The approach starts with taking persistent symptoms seriously rather than waiting, since a lung cancer caught while still operable is a completely different situation from one found late.

The whole battle with lung cancer is timing. A tumour found early, while it’s small and contained, can often be removed with a real chance of cure. The same cancer found months later, after the signs were dismissed, is a far harder fight. Knowing which symptoms to act on, and not waiting for them to become dramatic, is the single most useful thing a person at risk can do.

References

1. Early symptoms as predictors of lung cancer — National Library of Medicine
2. Early bodily sensations prior to lung cancer diagnosis — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

It can, but the risk is specific and largely preventable. The main danger is power morcellation, cutting the uterus into pieces inside the abdomen to remove it through small incisions. If an unsuspected cancer is present, that can scatter cells. The fix is proper assessment beforehand and removing the uterus intact when cancer is a possibility. Done right, the risk stays low.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “This is a real concern, and it deserves a straight answer. The problem comes from morcellation, grinding up the uterus to pull it out through keyhole incisions. If there’s a hidden sarcoma in there, you’ve just spread it. That’s exactly why I assess carefully first and remove the uterus whole when there’s any suspicion of cancer. Avoid that one mistake, and surgery is safe.”

The risk traces back to one specific technique used in some keyhole operations.

• Morcellation : To remove a large uterus through tiny incisions, it’s sometimes cut into pieces inside the abdomen. That cutting is where the danger lies.
• Hidden cancer : Occasionally a uterus thought to hold only fibroids contains an unsuspected sarcoma. Morcellating it scatters those cancer cells.
• Peritoneal seeding : The fragments can implant on the abdominal lining, turning a contained cancer into widespread disease. That worsens the outlook sharply.
• The FDA warning : Regulators flagged this years ago, cautioning against power morcellation in most fibroid surgeries precisely because of this risk.

This is why careful planning underpins every uterine cancer treatment, where the surgical method is chosen with this exact risk in mind.

Avoiding surgical spread comes down to assessment and technique, not luck.

• Assess first : Proper imaging and evaluation before surgery flags anything suspicious. Where cancer is possible, the whole plan changes accordingly.
• No morcellation if suspected : When cancer is on the table, the uterus isn’t cut up inside. It’s removed whole, full stop. That single rule prevents most spread.
• En bloc removal : The uterus comes out intact, often through the vagina, keeping any tumour contained within it. Nothing gets scattered.
• Containment bags : Where tissue extraction is needed, doing it inside a sealed bag stops stray cells from reaching the abdominal cavity.

Because most uterine cancers are caught early and treated by intact removal, the disease stays very treatable, which is covered in our guide on uterine cancer and when it can be cured.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. He performs minimally invasive uterine cancer surgery with the oncological discipline this risk demands, assessing carefully and removing the uterus intact whenever cancer is suspected. The approach treats surgical technique as part of the cancer treatment itself, since how the uterus comes out matters as much as that it comes out.

The difference here is judgement honed by treating cancer specifically, not just operating. A surgeon who understands the morcellation risk plans around it instinctively, choosing intact removal and proper containment without being told. For a woman facing uterine cancer surgery, that discipline is what keeps a curable, contained cancer from being turned into something far harder to treat.

References

1. Intraperitoneal spread after uterine morcellation — National Library of Medicine
2. Uterine malignancy rate in morcellated hysterectomy — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.